The latest survey of British Coatings Federation (BCF) members reveals UK coatings manufacturers are increasingly concerned about the effects of the new UK chemical regulations. Almost 80% of respondents believe UK REACH will impact negatively on their businesses, with the fear that there will be a significant reduction in the portfolio of available chemical substances in the UK compared to the EU, and 67% of respondents fear higher costs in the future where suppliers pass on the costs of complying with UK REACH. Worryingly, 19% of respondents are already reporting that EU suppliers no longer want to export to the UK.
The survey also reports challenges for the sector’s UK exporters – 60% fear that having to abide by EU REACH and CLP rules as a ‘third country’ will impact on their business competitiveness, and more than four in ten respondents (43%) reported increased operating costs of more than 5%, with one in ten (9%) citing a figure of more than 10%. These additional cost estimates have increased considerably since the last BCF Brexit Impact Survey at the end of January. On top of these non-tariff costs, the majority of BCF members are still encountering delays to shipping between UK and the EU, and between GB and NI. Overall, after experiencing nearly six months of the new UK-EU trading relationship, half of respondents are still concerned they risk losing EU export customers, and more than a third now worry about their competitiveness compared to EU counterparts as a result of the Trade and Co-operation Agreement (TCA) trading terms. 70% of coatings companies believe their trade with the EU, the sector’s main export market, will reduce, and only 20% see opportunities with the rest of the world from new trade deals.
Tom Bowtell, CEO of the British Coatings Federation, said: “Our latest survey results show that the added complexity of the new UK chemicals regulations is starting to bite. We have consistently called for UK REACH legislation to be amended to avoid the significant additional costs it will bring to business, as well as its potentially devastating impact on raw material availability to our manufacturers in the UK. Failure to amend UK REACH will lead to our coatings members – and other businesses in similar sectors – seeing unsustainable added complexities and extra costs. Exports of chemical-based products from the UK will be severely threatened by UK REACH, as will foreign direct investment into UK factories, as many companies choose to reduce their manufacturing footprint in the UK and relocate to the EU. Overall, the UK will become a less competitive country to do business in.”
“We welcome the fact that Defra has been engaging with industry on the future of UK REACH over the past few months and hope that, even at this late stage, UK REACH can be amended so that it is less damaging to UK businesses.”
Donald Trump’s tariffs of 50% have come into force on most US imports from India. India’s giant generic pharmaceuticals sector and its electronics and petroleum products are exempt from the tariffs. Aluminium, steel and copper remain at 25%, but job-heavy sectors such as textiles, jewellery, seafood and leather are squarely in the line of fire.
The European Chemicals Agency (ECHA) has published the updated proposal to restrict per- and polyfluoroalkyl substances (PFAS) under the EU’s chemicals regulation, REACH. The update has been prepared by the authorities from Denmark, Germany, the Netherlands, Norway and Sweden, who submitted the initial proposal in January 2023.
Most chemicals exported from the 27 member countries of the European Union into the US will be subject to a 15% tariff on top of their selling prices under an agreement signed on July 27 between the US and the European Commission.
We’re thrilled to announce a new strategic alliance between ExSyn, Exim-Indis and simABs, a leading EU-based biologics manufacturer known for its patented continuous flow technology in antibody production.
The global trade landscape is undergoing significant changes following the announcement of new reciprocal tariffs by the United States government. Recent developments indicate significant shifts in global trade dynamics, with key policy adjustments, ongoing negotiations, and evolving logistics patterns. Below is a summary of the latest developments.
In January 2025, the US FDA published a draft regulatory guidance entitled “The Considerations for Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products”.
The adoption of artificial intelligence (AI) and large language models (LLMs) is rapidly reshaping clinical research and drug development.
In the quest for increased sustainability, a lot has been made of the potential to use bio-based raw materials, captured CO2 and recycled plastics as raw materials for new chemicals. But what about using biotech processes to manufacture chemicals? Could it offer a more sustainable alternative to traditional petrochemical processing, and be more amenable to biobased raw materials?
High duties on imports from Canada, Mexico and China raise problems for international supply chains.